Skip to main content
Clinical Trials/NCT01907555
NCT01907555CompletedNot Applicable

Clinical, Molecular and Physiopathological Study of Cohen Syndrome and Cohen-like Syndromes

Centre Hospitalier Universitaire Dijon1 site in 1 country100 target enrollmentStarted: July 24, 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
spectrum of mutations VPS13B

Study Overview

Brief Summary

This project will make it possible to better understand the natural history of Cohen Syndrom and the phenotypes associated with mutations in the VPS13B gene, to improve the therapeutic management of patients. It will also provide a better description of Cohen-like syndrome for genetic counselling for the families concerned.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients presenting Cohen syndrome and two VPS13B mutations
  • who accept a clinical evaluation, and to provide at least one blood sample
  • Patients presenting the diagnostic criteria of Cohen syndrome, but without a VPS13B mutation
  • Patients presenting neutropenia or pigmentary retinopathy and at least one of the following signs, after exclusion of any other syndrome: mental retardation, microcephaly, truncal obesity

Exclusion Criteria

  • - Patients who do not meet the clinical and/or molecular criteria
  • Patients who do not wish to provide a blood sample for question 1,
  • Patients who have not provided written informed consent,
  • Pregnant or breast-feeding women,
  • Persons not covered by National Health Insurance and persons under guardianship or in prison.

Outcomes

Primary Outcomes

spectrum of mutations VPS13B

Time Frame: baseline

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Clinical, Molecular and Physiopathological... | Clinical Trial